Abstract:Cancer is a disease in which cells in the body grow out of control; breast cancer is the most common cancer in women in the United States. Due to early screening and advancements in therapeutic interventions, deaths from breast cancer have declined over time, although breast cancer remains the second leading cause of cancer death among women. Most deaths are due to metastasis, as cancer cells from the primary tumor in the breast form secondary tumors in remote sites in distant organs. Over many years, the basic biological mechanisms of breast cancer initiation and progression, as well as the subsequent metastatic cascade, have been studied using cell cultures and animal models. These models, although extremely useful for delineating cellular mechanisms, are poor predictors of physiological responses, primarily due to lack of proper microenvironments. In the last decade, microfluidics has emerged as a technology that could lead to a paradigm shift in breast cancer research. With the introduction of the organ-on-a-chip concept, microfluidic-based systems have been developed to reconstitute the dominant functions of several organs. These systems enable the construction of 3D cellular co-cultures mimicking in vivo tissue-level microenvironments, including that of breast cancer. Several reviews have been presented focusing on breast cancer formation, growth and metastasis, including invasion, intravasation, and extravasation. In this review, realizing that breast cancer can recur decades following post-treatment disease-free survival, we expand the discussion to account for microfluidic applications in the important areas of breast cancer detection, dormancy, and therapeutic development. It appears that, in the future, the role of microfluidics will only increase in the effort to eradicate breast cancer.

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Application of microfluidic chips in anticancer drug screening

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

Anti-Cancer Drug Screening with Microfluidic Technology

Construction of cancer-on-a-chip for drug screening

Bioprinting of Novel 3D Tumor Array Chip for Drug Screening

Multifunctional microfluidic chip for cancer diagnosis and treatment

Microfluidic Technologies in Advancing Cancer Research

Application of a Microfluidic Chip-Based 3D Co-Culture to Test Drug Sensitivity for Individualized Treatment of Lung Cancer.

Tumors on chips: oncology meets microfluidics

Tumor-on-a-chip: from bioinspired design to biomedical application

Microfluidics for Cancer Nanomedicine: From Fabrication to Evaluation

Application of Microfluidic Systems for Breast Cancer Research

Recent advances for cancer detection and treatment by microfluidic technology, review and update

Microfluidic Cell Culture Systems for Drug Research

Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

Drug screening on digital microfluidics for cancer precision medicine

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

Microengineering Methods for Cell-Based Microarrays and High-Throughput Drug-Screening Applications

Droplet Microfluidics for Current Cancer Research: From Single-Cell Analysis to 3D Cell Culture

Microfluidic modelling of the tumor microenvironment for anti-cancer drug development